PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 16:27:32 GMT 2025` Edited by `admin` on `Tue Apr 01 16:27:32 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	9B09G8YMGH
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA

Common Name

English

BETA PLATELET-DERIVED GROWTH FACTOR RECEPTOR

Preferred Name

English

CD140B

Common Name

English

PDGFR-B

Common Name

English

CD-140B

Common Name

English

BETA-TYPE PLATELET-DERIVED GROWTH FACTOR RECEPTOR

Common Name

English

PDGFR1

Common Name

English

Code System Code Type Description

FDA UNII

9B09G8YMGH

Created by admin on Tue Apr 01 16:27:32 GMT 2025 , Edited by admin on Tue Apr 01 16:27:32 GMT 2025

PRIMARY

PHAROS

P09619

Created by admin on Tue Apr 01 16:27:32 GMT 2025 , Edited by admin on Tue Apr 01 16:27:32 GMT 2025

PRIMARY

UNIPROT

P09619

Created by admin on Tue Apr 01 16:27:32 GMT 2025 , Edited by admin on Tue Apr 01 16:27:32 GMT 2025

PRIMARY

From	To
1_22	1_68
1_117	1_158
1_203	1_259
1_404	1_476

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_13
N	1_57
N	1_71
N	1_183
N	1_198
N	1_260
N	1_275
N	1_322
N	1_339
N	1_436
N	1_447

Related Record Type Details


					M59NC4E26P

MASITINIB

INHIBITOR -> TARGET


					3P63ZTE3OY

SERALUTINIB

INHIBITOR -> TARGET

Amount:


					G6HRD2P839

Nintedanib

INHIBITOR -> TARGET


					Y6UHU32G5Z

IDRX-42

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					WD3N2P38NO

3-HYDROXY-APATINIB, TRANS-

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					PP449XA4BH

LUCITANIB

INHIBITOR -> TARGET

Amount:


					X78UG0A0RN

DASATINIB ANHYDROUS

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					172030934T

TIVOZANIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					10E3O6YI4W

RINUCUMAB

PARENT->INNOVATOR


					E1IO3ICJ9A

TANDUTINIB

INHIBITOR -> TARGET

Amount:


					YP8G3I74EL

VOROLANIB

INHIBITOR -> TARGET


					ID912S5VON

MIDOSTAURIN

INHIBITOR -> TARGET


					18P7197Q7J

TELATINIB

INHIBITOR -> TARGET

Amount:


					6L5D03D975

ILORASERTIB

INHIBITOR -> TARGET

Amount:


					1B56C968OA

BECAPLERMIN

TARGET -> AGONIST


					5S371K6132

RIVOCERANIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					980M4N37DH

JI-101

INHIBITOR -> TARGET

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
	[1_530] [1_547] [1_549] [1_684] [1_708] [1_719] [1_731] [1_739] [1_743] [1_746] [1_825] [1_977] [1_989]		TYROSINE		TYROSINE O-PHOSPHATE	2R86C98KDX

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL